CASIRAGHI, VALERIA
 Distribuzione geografica
Continente #
AS - Asia 1.214
NA - Nord America 725
EU - Europa 685
SA - Sud America 122
OC - Oceania 89
AF - Africa 34
Totale 2.869
Nazione #
US - Stati Uniti d'America 693
CN - Cina 408
SG - Singapore 358
IT - Italia 265
BR - Brasile 102
HK - Hong Kong 94
IN - India 81
GB - Regno Unito 79
JP - Giappone 78
AU - Australia 77
DE - Germania 77
NL - Olanda 65
VN - Vietnam 50
RU - Federazione Russa 49
KR - Corea 43
TR - Turchia 37
FR - Francia 30
CH - Svizzera 20
ES - Italia 20
CI - Costa d'Avorio 19
CA - Canada 16
FI - Finlandia 15
MX - Messico 12
NZ - Nuova Zelanda 12
ID - Indonesia 11
CZ - Repubblica Ceca 10
SE - Svezia 10
IR - Iran 9
TW - Taiwan 9
AT - Austria 7
BE - Belgio 7
PK - Pakistan 7
ZA - Sudafrica 7
AR - Argentina 6
HR - Croazia 6
MY - Malesia 5
BD - Bangladesh 4
EC - Ecuador 4
HU - Ungheria 4
IE - Irlanda 4
MO - Macao, regione amministrativa speciale della Cina 4
CO - Colombia 3
EG - Egitto 3
IL - Israele 3
MA - Marocco 3
PH - Filippine 3
PL - Polonia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CL - Cile 2
GR - Grecia 2
LT - Lituania 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
AM - Armenia 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
HN - Honduras 1
KE - Kenya 1
MK - Macedonia 1
NI - Nicaragua 1
PE - Perù 1
SV - El Salvador 1
TH - Thailandia 1
UA - Ucraina 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.869
Città #
Singapore 148
Hefei 145
Ashburn 140
Dallas 126
Milan 82
Hong Kong 67
Beijing 59
Los Angeles 39
Sydney 37
Tokyo 37
Bengaluru 34
Munich 27
New York 26
Boardman 22
Ponte San Pietro 22
Abidjan 19
Buffalo 18
Hanoi 18
Körfez 17
Council Bluffs 16
Guangzhou 16
Rome 16
Santa Clara 15
São Paulo 15
Frankfurt am Main 14
Moscow 14
Wollongong 14
Baltimore 13
Ho Chi Minh City 13
Suwon 13
Auckland 12
Istanbul 12
Melbourne 12
Seoul 12
Utrecht 12
Pittsburgh 11
Amsterdam 10
London 10
Southwark 10
Cambridge 9
Framingham 9
Philadelphia 9
Chennai 8
Jakarta 8
Bergamo 7
Boston 7
Brisbane 7
City of London 7
Fukuoka 7
Kent 7
Paris 7
Rio de Janeiro 7
Washington 7
Brighton 6
Brooklyn 6
Greenwich 6
Houston 6
Keltern 6
New Delhi 6
Pavia 6
Queenstown Estate 6
Aliso Viejo 5
Cangzhou 5
Falkenstein 5
Florence 5
Kyoto 5
Mumbai 5
Pasadena 5
Rochester 5
San Mateo 5
Stockholm 5
Turin 5
Turku 5
Vancouver 5
Vienna 5
Zurich 5
Antwerp 4
Barcelona 4
Dublin 4
Düsseldorf 4
Fuzhou 4
Hanover 4
Helsinki 4
Hyderabad 4
Johannesburg 4
Lausanne 4
Madrid 4
Mainz 4
Montreal 4
Monza 4
Naples 4
Nashville 4
Oxford 4
Perth 4
Peschiera Borromeo 4
Prague 4
Ravenna 4
Rijeka 4
Sakaechō 4
San Carlos 4
Totale 1.668
Nome #
AGGREGATION MECHANISMS OF TDP-43 PROTEIN IN RESPONSE TO STRESS IN AMYOTROPHIC LATERAL SCLEROSIS AND THERAPEUTIC APPROACHES 320
Modeling of TDP-43 proteinopathy by chronic oxidative stress identifies rapamycin as beneficial in ALS patient-derived 2D and 3D iPSC models 306
Association of the risk factor UNC13A with survival and upper motor neuron involvement in amyotrophic lateral sclerosis 180
Modelling ALS disease by 2D and 3D in vitro models of patient-derived iPSC 160
Induced Pluripotent Stem Cell (iPSC)-derived Microglia and Organoids for neuronal disease modeling 155
Unraveling the role of NEK1 on primary cilia using mutant iPSC models 147
Rapamycin reverts TDP-43 splicing defects and mislocalization in human in vitro models of TDP-43 proteinopathy 123
Exploring epigenetic drift and rare epivariations in amyotrophic lateral sclerosis by epigenome-wide association study 111
Unraveling the role of primary cilia in the pathogenesis of amyotrophic lateral sclerosis 98
Characterization of human healthy i3 lower motor neurons exposed to CSF from ALS patients stratified by UNC13A and C9ORF72 genotype 86
Human in vitro models of TDP-43 proteinopathy for drug screening approaches 83
Rapamycin reverts TDP-43 splicing defects and mislocalization in human in vitro models of TDP-43 proteinopathy 81
Quantification of serum TDP-43 and neurofilament light chain in patients with amyotrophic lateral sclerosis stratified by UNC13A genotype 80
U1 snRNA as a novel RNA-based therapeutic approach to modulate C9ORF72 pathology in patient-derived iPSC-motoneurons 80
U1 snRNA as a novel RNA-based therapeutic approach to modulate C9ORF72 pathology in patient-derived iPSC-motoneurons 80
Rapamycin reverts TDP-43 splicing defects and oxidative stress-induced alterations in a human in vitro model of TDP-43 proteinopathy 79
Induced Pluripotent Stem Cell (iPSC)-derived Microglia for ALS modeling 70
Characterization of human healthy i3 lower motor neurons exposed to CSF from ALS patients stratified by UNC13A and C9ORF72 genotype 64
Rapamycin reverts TDP-43 splicing defects and mislocalization in human in vitro models of TDP-43 proteinopathy 63
Defective primary cilia in NEK1 and C9ORF72 iPSC-derived motoneurons and brain organoids 63
Induced Pluripotent Stem Cell (iPSC)-derived Microglia for ALS modeling 62
NEK1 haploinsufficiency worsens DNA damage, but not defective ciliogenesis, in C9ORF72 patient-derived iPSC-motoneurons 62
Characterization of human i3 motor neurons exposed to CSF from ALS patients stratified by C9ORF72 and UNC13A genotype 58
NEK1 loss-of-function mutation impairs ciliogenesis in iPSC-motoneurons 53
Characterization of human i3 motor neurons exposed to CSF from ALS patients stratified by C9ORF72 and UNC13A genotype 52
Characterization of human i3 motor neurons exposed to CSF from ALS patients stratified by C9ORF72 and UNC13A genotype 52
Defective primary cilia in NEK1 and C9ORF72 iPSC-derived motoneurons and brain organoids 52
Induced Pluripotent Stem Cell (iPSC)-derived Microglia for ALS modeling 52
Modeling a novel N-terminal mutation of KIF5A gene in patient-derived iPSC-motoneurons 48
Modelling ALS disease by 3D organoids culture from human-derived iPSC 40
Totale 2.960
Categoria #
all - tutte 6.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.923


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202331 0 0 0 0 0 0 0 1 14 12 2 2
2023/2024217 1 1 2 9 6 5 2 4 14 14 112 47
2024/2025846 51 65 25 51 27 29 51 50 35 84 99 279
2025/20261.866 349 370 535 374 201 37 0 0 0 0 0 0
Totale 2.960